Comparison of dapagliflozin 10 mg versus empagliflozin 10 mg in heart failure patients without type 2 diabetes mellitus on top of triple guideline-directed medical therapy


ÇÖLLÜOĞLU İ. T., ŞAHİN A., ÇELİK A., YILMAZ M. B., URAL D., NALBANTGİL S., ...More

Heart Failure 2025, Belgrade, Serbia, 17 - 20 May 2025, vol.27, pp.211, (Summary Text)

  • Publication Type: Conference Paper / Summary Text
  • Volume: 27
  • City: Belgrade
  • Country: Serbia
  • Page Numbers: pp.211
  • Çanakkale Onsekiz Mart University Affiliated: No